We are live on
!
Find out more
PL
Pluribus Labs Portfolio holdings
AUM
$54.8M
This Fund
S&P 500
This Quarter
Est. Return
-2.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25.2M
AUM Growth
-$69.7M
(-73%)
Cap. Flow
-$68.8M
Cap. Flow
% of AUM
-273.42%
Top 10 Holdings %
Top 10 Hldgs %
58.31%
Holding
244
New
16
Increased
13
Reduced
15
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$505K |
| 2 |
Blackrock
BLK
|
+$373K |
| 3 |
Prologis
PLD
|
+$358K |
| 4 |
IBM
IBM
|
+$321K |
| 5 |
Lockheed Martin
LMT
|
+$310K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$1.04M |
| 2 |
Public Service Enterprise Group
PEG
|
+$879K |
| 3 |
Verizon
VZ
|
+$872K |
| 4 |
QVCGA
QVC Group Inc Series A
QVCGA
|
+$813K |
| 5 |
MasTec
MTZ
|
+$788K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Consumer Discretionary | 15.05% |
| 3 | Healthcare | 13.51% |
| 4 | Communication Services | 13.02% |
| 5 | Financials | 12.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Sun Communities
SUI
$15B
| – | – |
-1,146
| Closed | -$241K |
|
202
Stryker
SYK
$127B
| – | – |
-1,354
| Closed | -$362K |
|
203
Teladoc Health
TDOC
$1.58B
| – | – |
-2,744
| Closed | -$252K |
|
204
Telephone and Data Systems
TDS
$3.91B
| – | – |
-22,957
| Closed | -$463K |
|
205
Bio-Techne
TECH
$11.2B
| – | – |
-3,212
| Closed | -$415K |
|
206
Taylor Morrison
TMHC
| – | – |
-15,981
| Closed | -$559K |
|
207
Toll Brothers
TOL
$14B
| – | – |
-4,976
| Closed | -$360K |
|
208
Trinity Industries
TRN
$2.97B
| – | – |
-16,681
| Closed | -$504K |
|
209
Union Pacific
UNP
$183B
| – | – |
-1,648
| Closed | -$415K |
|
210
Utz Brands
UTZ
$1.25B
| – | – |
-16,863
| Closed | -$269K |
|
211
Universal Corp
UVV
$1.34B
| – | – |
-10,815
| Closed | -$594K |
|
212
Veeva Systems
VEEV
$30.3B
| – | – |
-899
| Closed | -$230K |
|
213
Valmont Industries
VMI
$9.44B
| – | – |
-1,264
| Closed | -$317K |
|
214
Vroom Inc
VRM
$36.9M
| – | – |
-138
| Closed | -$119K |
|
215
Valvoline
VVV
$4.97B
| – | – |
-9,044
| Closed | -$337K |
|
|
216
Verizon
VZ
$194B
| – | – |
-16,779
| Closed | -$872K |
|
217
Wabtec
WAB
$51.1B
| – | – |
-3,182
| Closed | -$293K |
|
218
Western Alliance Bancorporation
WAL
$9.07B
| – | – |
-2,926
| Closed | -$315K |
|
|
WCC
219
WESCO International
WCC
$16.2B
| – | – |
-1,697
| Closed | -$223K |
|
220
Walker & Dunlop
WD
$1.65B
| – | – |
-1,528
| Closed | -$231K |
|
221
WEC Energy
WEC
$37.7B
| – | – |
-3,836
| Closed | -$372K |
|
222
Weyerhaeuser
WY
$17.3B
| – | – |
-5,982
| Closed | -$246K |
|
223
Xcel Energy
XEL
$51B
| – | – |
-7,854
| Closed | -$532K |
|
224
XPO
XPO
$25B
| – | – |
-5,318
| Closed | -$245K |
|
225
Dentsply Sirona
XRAY
$2.59B
| – | – |
-5,639
| Closed | -$315K |
|
Similar funds
BAM
KIP
CRCM
FA
LCM
IRF
ACI
NPGCU
Pluribus Labs's Q1 2022 Portfolio in Review
As of Q1 2022, Pluribus Labs held 244 positions worth $25.2M, down 73% from $94.8M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Pluribus Labs withdrew a net $68.8M in Q1 2022, closing 200 positions and reducing 15 holdings. Its most notable exit was Marsh, an estimated $1.04M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Pluribus Labs opened a new position in Merck worth $526K.
- Pluribus Labs's largest Q1 2022 buy was Merck: 6,405 shares worth $526K.
- Pluribus Labs added most to Apple in Q1 2022, an estimated $289K increase.
- Pluribus Labs's biggest Q1 2022 reduction was Johnson & Johnson, cutting an estimated $647K.
- Pluribus Labs fully exited Marsh in Q1 2022, selling an estimated $1.04M.
- Pluribus Labs's ten largest holdings make up 58% of its $25.2M portfolio in Q1 2022.
- Pluribus Labs opened 16 new positions and closed 200 in Q1 2022.
- Pluribus Labs's portfolio value fell 73% quarter-over-quarter to $25.2M.
Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.